Given our recovery of Akkermansia organisms, the colonic AHR level, and the number of goblet cells in the metformin or FOS intervention mice, we next assessed hepatic inflammation and steatosis in sucralose-treated mice. The gene discussed is AHR; the disease is steatosis.